Advestra with EvlaBio on financing round

Advestra advised life sciences startup EvlaBio on its EUR 21 million seed financing round.

Headquartered in Zurich, EvlaBio specialises in the development of therapies for Left Ventricular Hypertrophy (LVH) in the context of Chronic Kidney Disease (CKD).

French VC firm Kurma Partners led the operation , with AdBio Partners (Paris, Barcelona), Boehringer Ingelheim Venture Fund, NRW.Venture (NRW.Bank) and High-Tech Gründerfonds acting as co-investors.

The Advestra team

The Advestra lineup included Alexander von Jeinsen (pictured), Daniel Raun, Anna Capaul and Fabian Loretan (all Corporate M&A).

flavio.caci@lcpublishinggroup.com

SHARE